HFEA widens its criteria for preimplantation genetic diagnosis
BMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7551.1174 (Published 18 May 2006) Cite this as: BMJ 2006;332:1174- Clare Dyer, legal correspondent
- BMJ
Screening embryos for a wider range of genetic conditions was given the go ahead by the Human Fertilisation and Embryology Authority (HFEA), the United Kingdom's fertility watchdog, last week.
Preimplantation genetic diagnosis was already approved for a limited number of conditions with which a baby is born—such as cystic fibrosis—or that it risks developing early in life—for example, the cancers retinoblastoma and familial adenomatous polyposis. Both cancers have “high penetrance”—children born with the genetic mutation have a 90% chance of developing the condition.
Last …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.